黑质
多巴胺能
多巴胺
程序性细胞死亡
p38丝裂原活化蛋白激酶
发病机制
细胞生物学
酪氨酸羟化酶
帕金森病
生物
MAPK/ERK通路
信号转导
化学
内科学
内分泌学
医学
生物化学
疾病
细胞凋亡
作者
Tien‐Chun Yang,Pei‐Chun Wu,I‐Fang Chung,Jhih‐Hang Jiang,Ming‐Ji Fann,Lung‐Sen Kao
摘要
Abstract The pathogenesis of Parkinson's disease (PD) is not completely understood, Zinc (Zn 2+ ) and dopamine (DA) have been shown to involve in the degeneration of dopaminergic cells. By microarray analysis, we identified Gadd45b as a candidate molecule that mediates Zn 2+ and DA‐induced cell death; the mRNA and protein levels of Gadd45b are increased by Zn 2+ treatment and raised to an even higher level by Zn 2+ plus DA treatment. Zn 2+ plus DA treatment‐induced PC12 cell death was enhanced when there was over‐expression of Gadd45b and was decreased by knock down of Gadd45b. MAPK p38 and JNK signaling was able to cross‐talk with Gadd45b during Zn 2+ and DA treatment. The synergistic effects of Zn 2+ and DA on PC12 cell death can be accounted for by an activation of the Gadd45b‐induced cell death pathway and an inhibition of p38/JNK survival pathway. Furthermore, the in vivo results show that the levels of Gadd45b protein expression and phosphorylation of p38 were increased in the substantia nigra by the infusion of Zn 2+ /DA in the mouse brain and the level of Gadd45b mRNA is significantly higher in the substantia nigra of male PD patients than normal controls. The novel role of Gadd45b and its interactions with JNK and p38 will help our understanding of the pathogenesis of PD and help the development of future treatments for PD. image Zinc and dopamine are implicated in the degeneration of dopaminergic neurons. We previously demonstrated that zinc and dopamine induced synergistic effects on PC12 cell death. Results from this study show that these synergistic effects can be accounted for by activation of the Gadd45b‐induced cell death pathway and inhibition of the p38/JNK survival pathway. We provide in vitro and in vivo evidence to support a novel role for Gadd45b in the pathogenesis of Parkinson's disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI